Aug 01, 2017 20:05 pm UTC| Business
REHOVOT, Israel, Aug. 01, 2017 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, today announced that it will hold...
Tactile Medical Announces Appointment of Cheryl Pegus to Board of Directors
Aug 01, 2017 20:05 pm UTC| Business
MINNEAPOLIS, Aug. 01, 2017 -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today...
Ocera Therapeutics Reports Second Quarter 2017 Financial Results
Aug 01, 2017 20:05 pm UTC| Business
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., Aug. 01, 2017 -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on the development of OCR-002 for the treatment and...
Aug 01, 2017 20:05 pm UTC| Business
ROCKVILLE, Md., Aug. 01, 2017 -- REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV®...
MRI Interventions, Inc. Reports 79% Revenue Increase and Record Treatments in Second Quarter 2017
Aug 01, 2017 20:05 pm UTC| Business
IRVINE, Calif., Aug. 01, 2017 -- MRI Interventions, Inc. (OTCQB:MRIC) (the “Company”) today announced financial results for the second quarter ended June 30, 2017. 2017 Second Quarter and Recent Highlights Total...
Aug 01, 2017 20:05 pm UTC| Business
Commercial Financial Highlights Revenue of $35.6 million in second quarter 2017, an increase of 80 percent from second quarter 2016 2017 revenue guidance increased by $20 million, to $145-155 millionGAAP net income of...
TRACON to Report Second Quarter Company Highlights and Financial Results on August 8, 2017
Aug 01, 2017 20:05 pm UTC| Business
SAN DIEGO, Aug. 01, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...